
Injective (INJ) surged 15% this week, breaking a multi-month bearish trend. With its EVM testnet launch, rising adoption, and bullish technical momentum, INJ eyes $15+. (Read More)

Injective (INJ) surged 15% this week, breaking a multi-month bearish trend. With its EVM testnet launch, rising adoption, and bullish technical momentum, INJ eyes $15+. (Read More)